Expression analysis of a cholecystokinin system in human and rat white adipose tissue

Life Sci. 2018 Aug 1:206:98-105. doi: 10.1016/j.lfs.2018.05.036. Epub 2018 May 23.

Abstract

Aim: Cholecystokinin (CCK) participates in the storage of dietary triglycerides in white adipose tissue (WAT). Our goal was to characterize, both in subcutaneous (Sc-WAT) and visceral WAT (Vis-WAT), the functional expression of the two known CCK receptors, CCK-1 (CCK-1R) and CCK-2 (CCK-2R), as well as of CCK.

Main methods: Gene and protein expression was assessed in different cell types of rat and human WAT by means of RT-PCR and western-blot, respectively. The functionality of CCK-Rs was tested by quantifying protein kinase B (Akt) phosphorylation after treatment of pre-adipocytes with the bioactive fragment of CCK, CCK-8. The CCK receptor subtype involved in Akt phosphorylation was investigated by using selective CCK-1R (SR-27,897) and CCK-2R antagonists (L-365,260).

Key findings: In rats, CCK-1R (Cckar) and CCK-2R (Cckbr) gene expression was detected in the two types of WAT analyzed as well as in isolated adipocytes, mesenchymal stem cells and pre-adipocytes. CCK-1R and CCK-2R proteins were identified in adipocytes and, to a minor extent, in pre-adipocytes. In addition, CCK-2R were detected in subcutaneous mesenchymal stem cells. Gene expression of the CCK precursor preproCCK as well as CCK immunoreactivity were also found in Sc-WAT and Vis-WAT. In human WAT, CCK gene expression as well as CCK-2Rs and CCK were also identified. CCK-8 evoked Akt phosphorylation in rat pre-adipocytes, and this effect was antagonized by SR-27,897 and L-365,260.

Significance: Our data show that both human and rat WAT express a complete CCK system, and suggest that CCK may have an autocrine/paracrine role in regulating adipose tissue biology.

Keywords: Adipocyte; Mesenchymal stem cells; Protein kinase B; Receptors, cholecystokinin.

MeSH terms

  • Adipocytes / metabolism
  • Adipose Tissue, White / metabolism*
  • Adipose Tissue, White / physiology*
  • Animals
  • Benzodiazepinones / pharmacology
  • Cholecystokinin / metabolism*
  • Cholecystokinin / physiology*
  • Gene Expression Regulation / genetics
  • Gene Silencing
  • Humans
  • Indoleacetic Acids / pharmacology
  • Male
  • Mesenchymal Stem Cells / metabolism
  • Oncogene Protein v-akt / genetics
  • Oncogene Protein v-akt / metabolism
  • Phenylurea Compounds / pharmacology
  • Phosphorylation
  • Rats
  • Rats, Wistar
  • Receptor, Cholecystokinin A / antagonists & inhibitors
  • Receptor, Cholecystokinin A / biosynthesis
  • Receptor, Cholecystokinin A / genetics
  • Receptor, Cholecystokinin B / antagonists & inhibitors
  • Receptor, Cholecystokinin B / biosynthesis
  • Receptor, Cholecystokinin B / genetics
  • Thiazoles / pharmacology

Substances

  • Benzodiazepinones
  • Indoleacetic Acids
  • Phenylurea Compounds
  • Receptor, Cholecystokinin A
  • Receptor, Cholecystokinin B
  • Thiazoles
  • SR 27897
  • L 365260
  • Cholecystokinin
  • Oncogene Protein v-akt